We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Ice Slurry for Sudden Cardiac Arrest

By HospiMedica staff writers
Posted on 26 Sep 2002
Emergency medicine researchers are developing ways to use ice slurry, a high-fluidity ice particle mixture, to rapidly cool the blood and sustain the heart and brain cells following cardiac arrest.

People who suffer cardiac arrest outside the hospital have a lower chance of recovering, since brain cells start dying rapidly 10-12 minutes later because of a lack of blood flow to the brain. When cells are cooled, their metabolism and chemical processes slow dramatically. The researchers believe ice slurry could be injected into the body to induce faster, internal cooling. Because of its high cooling capacity, ice slurry could cool critical organs very rapidly with only a small amount of coolant.

In the procedure, the slurry would be inserted into the lungs, cooling the surrounding blood. Medics would need to perform chest compressions to circulate the cooled blood, allowing it to reach the brain and preserve cells. Data collected by the researchers show that ice slurry cools the brain by 2-5o C very quickly and appears to keep the brain cool for an hour. This would give medics and doctors more time to revive normal blood flow and reduce brain damage to little or none. The research is being conducted by investigators at the University of Chicago's Emergency Resuscitation Center (UC, IL, USA; www.uchicago.edu) and the US Argonne National Laboratory (at UC; www.anl.gov) under a US$4 million grant from the US National Institutes of Health.

"With the grant, we can further develop our tools, make even better slurry, and hopefully move closer to the point where it's possible to do human trials,” says Ken Kasza, a senior mechanical engineer who heads the research at Argonne.





Related Links:
Univ. Chicago

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Pediatric Cart
UXGLA-9PEDS
New
Clinical Display
C14S

Latest Critical Care News

Breakthrough Technique Stops Irregular Heartbeats

AI Model Accurately Predicts Progression of Autoimmune Disease

AI Predicts and Identifies Subtypes of Type 2 Diabetes from Continuous Blood Glucose Monitor